Monoclonal Clinical Trials in Chapel Hill, North Carolina
3 recruitingChapel Hill, North Carolina
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Multiple MyelomaMonoclonal Gammopathy of Renal Significance
Memorial Sloan Kettering Cancer Center20 enrolled11 locationsNCT06083922
Recruiting
Registry for Adults With Plasma Cell Disorders (PCD's)
Multiple MyelomaAmyloidosisSmoldering Multiple Myeloma+6 more
UNC Lineberger Comprehensive Cancer Center2,000 enrolled1 locationNCT03717844
Recruiting
Phase 2
Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
Proliferative Glomerulonephritis With Monoclonal IgG Deposits
Mayo Clinic40 enrolled4 locationsNCT05654506